138 related articles for article (PubMed ID: 26632380)
1. Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines.
Jung YS; Kim HJ; Seo SK; Choi YS; Nam EJ; Kim S; Kim SW; Han HD; Kim JW; Kim YT
Yonsei Med J; 2016 Jan; 57(1):33-40. PubMed ID: 26632380
[TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.
Renlund N; Pieretti-Vanmarcke R; O'Neill FH; Zhang L; Donahoe PK; Teixeira J
Endocrinology; 2008 Jan; 149(1):108-15. PubMed ID: 17947357
[TBL] [Abstract][Full Text] [Related]
3. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract][Full Text] [Related]
4. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
5. [Effect of extracellular signal regulated kinase signal pathway on apoptosis induced by MG262 in ovarian cancer cells].
Wang WX; Kong BH; Li P; Song K; Qu X; Cui BX; Jiang J; Zhang YZ; Yang XS
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):690-4. PubMed ID: 19087521
[TBL] [Abstract][Full Text] [Related]
6. Prucalopride Inhibits Proliferation of Ovarian Cancer Cells via Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway.
Liu X; Xu Y; Zhang L; Liu T; Zhang H
Med Sci Monit; 2018 Jun; 24():4137-4145. PubMed ID: 29909423
[TBL] [Abstract][Full Text] [Related]
7. YWK-II protein as a novel G(o)-coupled receptor for Müllerian inhibiting substance in cell survival.
Yin X; Ouyang S; Xu W; Zhang X; Fok KL; Wong HY; Zhang J; Qiu X; Miao S; Chan HC; Wang L
J Cell Sci; 2007 May; 120(Pt 9):1521-8. PubMed ID: 17452623
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.
Basal E; Ayeni T; Zhang Q; Langstraat C; Donahoe PK; Pepin D; Yin X; Leof E; Cliby W
Curr Mol Med; 2016; 16(3):222-31. PubMed ID: 26917267
[TBL] [Abstract][Full Text] [Related]
9. Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line.
Teekaraman D; Elayapillai SP; Viswanathan MP; Jagadeesan A
Chem Biol Interact; 2019 Feb; 300():91-100. PubMed ID: 30639267
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival.
Chauvin M; Garambois V; Choblet S; Colombo PE; Chentouf M; Gros L; De Brauwere DP; Duonor-Cerutti M; Dumas K; Robert B; Jarlier M; Martineau P; Navarro-Teulon I; Pépin D; Chardès T; Pèlegrin A
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013359
[TBL] [Abstract][Full Text] [Related]
12. Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.
Pieretti-Vanmarcke R; Donahoe PK; Pearsall LA; Dinulescu DM; Connolly DC; Halpern EF; Seiden MV; MacLaughlin DT
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17426-31. PubMed ID: 17088539
[TBL] [Abstract][Full Text] [Related]
13. Identification of large-scale characteristic genes of Müllerian inhibiting substance in human ovarian cancer cells.
Nam SW; Jo YS; Eun JW; Song JY; Ryu KS; Lee JY; Lee JM; Maclaughlin DT; Kim JH
Int J Mol Med; 2009 May; 23(5):589-96. PubMed ID: 19360316
[TBL] [Abstract][Full Text] [Related]
14. Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis.
Namkung J; Song JY; Jo HH; Kim MR; Lew YO; Donahoe PK; MacLaughlin DT; Kim JH
J Clin Endocrinol Metab; 2012 Sep; 97(9):3224-30. PubMed ID: 22761458
[TBL] [Abstract][Full Text] [Related]
15. Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.
Song JY; Jo HH; Kim MR; Lew YO; Ryu KS; Cha JH; Kang CS; Donahoe PK; MacLaughlin DT; Kim JH
Int J Oncol; 2012 Jun; 40(6):2013-21. PubMed ID: 22344630
[TBL] [Abstract][Full Text] [Related]
16. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
18. AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.
Pépin D; Sosulski A; Zhang L; Wang D; Vathipadiekal V; Hendren K; Coletti CM; Yu A; Castro CM; Birrer MJ; Gao G; Donahoe PK
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4418-27. PubMed ID: 26216943
[TBL] [Abstract][Full Text] [Related]
19. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
20. Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.
Hwang SJ; Suh MJ; Yoon JH; Kim MR; Ryu KS; Nam SW; Donahoe PK; Maclaughlin DT; Kim JH
Int J Oncol; 2011 Oct; 39(4):811-20. PubMed ID: 21573503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
